Literature DB >> 18959837

Genetic determinants of hypertension: an update.

Michael Harrison1, Karen Maresso, Ulrich Broeckel.   

Abstract

Hypertension represents a global public health burden. In addition to the rarer Mendelian forms of hypertension, classic genetic studies have documented a significant heritable component to the most common form, essential hypertension (EH). Extensive efforts are under way to elucidate the genetic basis of this disease. Recently, a new form of Mendelian hypertension has been identified, pharmacogenetic association studies in hypertensive patients have identified novel gene-by-drug interactions, and the first genome-wide association studies of EH have been published. New findings in consomic and congenic rat models also offer new clues to the genetic architecture of this complex phenotype. In this review, the authors summarize and evaluate the most recent findings related to hypertension gene identification.

Entities:  

Mesh:

Year:  2008        PMID: 18959837     DOI: 10.1007/s11906-008-0091-1

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  46 in total

1.  Role of genetic factors in susceptibility to experimental hypertension due to chronic excess salt ingestion.

Authors:  L K DAHL; M HEINE; L TASSINARI
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

Review 2.  Elevated systolic blood pressure as a cardiovascular risk factor.

Authors:  W B Kannel
Journal:  Am J Cardiol       Date:  2000-01-15       Impact factor: 2.778

Review 3.  The genetic dissection of essential hypertension.

Authors:  Allen W Cowley
Journal:  Nat Rev Genet       Date:  2006-10-10       Impact factor: 53.242

Review 4.  Worldwide prevalence of hypertension: a systematic review.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul K Whelton; Jiang He
Journal:  J Hypertens       Date:  2004-01       Impact factor: 4.844

5.  Common variants in genes underlying monogenic hypertension and hypotension and blood pressure in the general population.

Authors:  Martin D Tobin; Maciej Tomaszewski; Peter S Braund; Cother Hajat; Stuart M Raleigh; Thomas M Palmer; Mark Caulfield; Paul R Burton; Nilesh J Samani
Journal:  Hypertension       Date:  2008-04-28       Impact factor: 10.190

6.  A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension.

Authors:  R P Lifton; R G Dluhy; M Powers; G M Rich; S Cook; S Ulick; J M Lalouel
Journal:  Nature       Date:  1992-01-16       Impact factor: 49.962

7.  Liddle disease caused by a missense mutation of beta subunit of the epithelial sodium channel gene.

Authors:  H Tamura; L Schild; N Enomoto; N Matsui; F Marumo; B C Rossier
Journal:  J Clin Invest       Date:  1996-04-01       Impact factor: 14.808

8.  Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase.

Authors:  T Mune; F M Rogerson; H Nikkilä; A K Agarwal; P C White
Journal:  Nat Genet       Date:  1995-08       Impact factor: 38.330

Review 9.  Masked hypertension definition, impact, outcomes: a critical review.

Authors:  Dimitris P Papadopoulos; Thomas K Makris
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-12       Impact factor: 3.738

10.  Framingham Heart Study 100K Project: genome-wide associations for blood pressure and arterial stiffness.

Authors:  Daniel Levy; Martin G Larson; Emelia J Benjamin; Christopher Newton-Cheh; Thomas J Wang; Shih-Jen Hwang; Ramachandran S Vasan; Gary F Mitchell
Journal:  BMC Med Genet       Date:  2007-09-19       Impact factor: 2.103

View more
  16 in total

Review 1.  Dopamine, the kidney, and hypertension.

Authors:  Raymond C Harris; Ming-Zhi Zhang
Journal:  Curr Hypertens Rep       Date:  2012-04       Impact factor: 5.369

Review 2.  Genetic associations with hypertension: meta-analyses of six candidate genetic variants.

Authors:  Cheng Zhang; Lingyan Wang; Qi Liao; Lina Zhang; Leiting Xu; Cheng Chen; Huadan Ye; Xuting Xu; Meng Ye; Shiwei Duan
Journal:  Genet Test Mol Biomarkers       Date:  2013-07-16

Review 3.  Abnormalities in renal dopamine signaling and hypertension: the role of GRK4.

Authors:  Raymond C Harris
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-01       Impact factor: 2.894

4.  Common polymorphisms (rs2241766 and rs1501299) in the ADIPOQ gene are not associated with hypertension susceptibility among the Chinese.

Authors:  Bo Xi; Dan He; Qijuan Wang; Jian Xue; Man Liu; Jun Li
Journal:  Mol Biol Rep       Date:  2012-06-20       Impact factor: 2.316

Review 5.  Dopamine and G protein-coupled receptor kinase 4 in the kidney: role in blood pressure regulation.

Authors:  Pedro A Jose; Patricio Soares-da-Silva; Gilbert M Eisner; Robin A Felder
Journal:  Biochim Biophys Acta       Date:  2010-02-12

6.  Associations of polymorphisms in the β2-adrenergic receptor gene with essential hypertension in Han Chinese population.

Authors:  Zhenwang Tang; Xingsheng Li; Duanfang Liao
Journal:  Mol Biol Rep       Date:  2012-07-05       Impact factor: 2.316

Review 7.  Opportunities and limitations of genetic analysis of hypertensive rat strains.

Authors:  Juan M Saavedra
Journal:  J Hypertens       Date:  2009-06       Impact factor: 4.844

8.  Evidence on the causal link between homocysteine and hypertension from a meta-analysis of 40 173 individuals implementing Mendelian randomization.

Authors:  Liwan Fu; Ya-Nan Li; Dongmei Luo; Shufang Deng; Baihui Wu; Yue-Qing Hu
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-11-25       Impact factor: 3.738

9.  Construction and analysis of the protein-protein interaction network related to essential hypertension.

Authors:  Jihua Ran; Hui Li; Jianfeng Fu; Ling Liu; Yanchao Xing; Xiumei Li; Hongming Shen; Yan Chen; Xiaofang Jiang; Yan Li; Huiwu Li
Journal:  BMC Syst Biol       Date:  2013-04-12

10.  Inflammation and hypertension: are there regional differences?

Authors:  Patricio López-Jaramillo; Carlos Velandia-Carrillo; Julie Alvarez-Camacho; Daniel Dylan Cohen; Tatiana Sánchez-Solano; Gabriela Castillo-López
Journal:  Int J Hypertens       Date:  2013-03-21       Impact factor: 2.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.